Search Results - "ABEI, Masato"

Proton Beam Therapy for Hepatocellular Carcinoma: A Comparison of Three Treatment Protocols by Mizumoto, Masashi, M.D, Okumura, Toshiyuki, M.D, Hashimoto, Takayuki, M.D, Fukuda, Kuniaki, M.D, Oshiro, Yoshiko, M.D, Fukumitsu, Nobuyoshi, M.D, Abei, Masato, M.D, Kawaguchi, Atsushi, Ph.D, Hayashi, Yasutaka, M.D, Ookawa, Ayako, M.D, Hashii, Haruko, M.D, Kanemoto, Ayae, M.D, Moritake, Takashi, M.D, Tohno, Eriko, M.D, Tsuboi, Koji, M.D, Sakae, Takeji, Ph.D, Sakurai, Hideyuki, M.D

“…Background Our previous results for treatment of hepatocellular carcinoma (HCC) with proton beam therapy revealed excellent local control with low toxicity…”
Get full text

Proton Beam Therapy for Large Hepatocellular Carcinoma by Sugahara, Shinji, M.D, Oshiro, Yoshiko, M.D, Nakayama, Hidetsugu, M.D, Fukuda, Kuniaki, M.D, Mizumoto, Masashi, M.D, Abei, Masato, M.D, Shoda, Junichi, M.D, Matsuzaki, Yasushi, M.D, Thono, Eriko, M.D, Tokita, Mari, B.A, Tsuboi, Koji, M.D, Tokuuye, Koichi, M.D

“…Purpose To investigate the safety and efficacy of proton beam therapy (PBT) in patients with large hepatocellular carcinoma (HCC). Methods and Materials…”
Get full text

Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma by Fukuda, Kuniaki, Okumura, Toshiyuki, Abei, Masato, Fukumitsu, Nobuyoshi, Ishige, Kazunori, Mizumoto, Masashi, Hasegawa, Naoyuki, Numajiri, Haruko, Ohnishi, Kayoko, Ishikawa, Hitoshi, Tsuboi, Koji, Sakurai, Hideyuki, Hyodo, Ichinosuke

“…Long‐term efficacy of proton beam therapy (PBT) remains unclear for patients with previously untreated hepatocellular carcinoma (HCC). We aimed to study the…”
Get full text

Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin‐3 in gastric cancer cells by Endo, Shinji, Yamato, Kenji, Hirai, Sachiko, Moriwaki, Toshikazu, Fukuda, Kuniaki, Suzuki, Hideo, Abei, Masato, Nakagawa, Ichiro, Hyodo, Ichinosuke

“…The tumor suppressor gene p53 is the most frequently mutated gene in human cancers. However, its mutation rate is relatively low in gastric cancer compared…”
Get full text

Proton beam therapy for unresectable intrahepatic cholangiocarcinoma by Ohkawa, Ayako, Mizumoto, Masashi, Ishikawa, Hitoshi, Abei, Masato, Fukuda, Kuniaki, Hashimoto, Takayuki, Sakae, Takeji, Tsuboi, Koji, Okumura, Toshiyuki, Sakurai, Hideyuki

“…Background and Aim Treatment for unresectable intrahepatic cholangiocarcinoma (ICC) has not been established. The aim of the study was to evaluate the outcome…”
Get full text

A Prospective Study of Hypofractionated Proton Beam Therapy for Patients With Hepatocellular Carcinoma by Fukumitsu, Nobuyoshi, M.D, Sugahara, Shinji, M.D, Nakayama, Hidetsugu, M.D, Fukuda, Kuniaki, M.D, Mizumoto, Masashi, M.D, Abei, Masato, M.D, Shoda, Junichi, M.D, Thono, Eriko, M.D, Tsuboi, Koji, M.D, Tokuuye, Koichi, M.D

“…Purpose To evaluate the efficacy and safety of hypofractionated proton beam therapy for patients with hepatocellular carcinoma (HCC). Methods and Materials…”
Get full text

Proton Beam Therapy for Hepatocellular Carcinoma Located Adjacent to the Alimentary Tract by Nakayama, Hidetsugu, M.D, Sugahara, Shinji, M.D, Fukuda, Kuniaki, M.D, Abei, Masato, M.D, Shoda, Junichi, M.D, Sakurai, Hideyuki, M.D, Tsuboi, Koji, M.D, Matsuzaki, Yasushi, M.D, Tokuuye, Koichi, M.D., Ph.D

“…Purpose To evaluate the safety and effectiveness of proton beam therapy for hepatocellular carcinoma (HCC) located adjacent to the alimentary tract. Patients…”
Get full text

Evaluation of Liver Function After Proton Beam Therapy for Hepatocellular Carcinoma by Mizumoto, Masashi, M.D, Okumura, Toshiyuki, M.D, Hashimoto, Takayuki, M.D, Fukuda, Kuniaki, M.D, Oshiro, Yoshiko, M.D, Fukumitsu, Nobuyoshi, M.D, Abei, Masato, M.D, Kawaguchi, Atsushi, Ph.D, Hayashi, Yasutaka, M.D, Ohkawa, Ayako, M.D, Hashii, Haruko, M.D, Kanemoto, Ayae, M.D, Moritake, Takashi, M.D, Tohno, Eriko, M.D, Tsuboi, Koji, M.D, Sakae, Takeji, Ph.D, Sakurai, Hideyuki, M.D

“…Purpose Our previous results for treatment of hepatocellular carcinoma with proton beam therapy (PBT) revealed excellent local control. In this study, we…”
Get full text

Impact of Solute Carrier Family 29 Member 1 (SLC29A1) Single Nucleotide Polymorphisms on mRNA Expression in Peripheral Blood Mononuclear Cells by Suzuki, Yoshiharu, Homma, Masato, Abei, Masato, Hyodo, Ichinosuke, Kohda, Yukinao

“…The effects of solute carrier family 29 member 1 (SLC29A1) single nucleotide polymorphism (SNP), rs6932345 and rs747199, on SLC29A1 mRNA expression were…”
Get full text

Antitumor effects of a sirtuin inhibitor, tenovin-6, against gastric cancer cells via death receptor 5 up-regulation by Hirai, Sachiko, Endo, Shinji, Saito, Rie, Hirose, Mitsuaki, Ueno, Takunori, Suzuki, Hideo, Yamato, Kenji, Abei, Masato, Hyodo, Ichinosuke

“…Up-regulated sirtuin 1 (SIRT1), an NAD+-dependent class III histone deacetylase, deacetylates p53 and inhibits its transcriptional activity, leading to cell…”
Get full text

Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Porta Hepatis by Mizumoto, Masashi, M.D, Tokuuye, Koichi, M.D, Sugahara, Shinji, M.D, Nakayama, Hidetsugu, M.D, Fukumitsu, Nobuyoshi, M.D, Ohara, Kiyoshi, M.D, Abei, Masato, M.D, Shoda, Junichi, M.D, Tohno, Eriko, M.D, Minami, Manabu, M.D

“…Purpose To evaluate the efficacy and safety of proton beam therapy (PBT) for patients with hepatocellular carcinoma (HCC) located adjacent to the porta…”
Get full text

Oncolytic Virotherapy and Gene Therapy Strategies for Hepatobiliary Cancers by Yamada, Takeshi, Hamano, Yukako, Hasegawa, Naoyuki, Seo, Emiko, Fukuda, Kuniaki, Yokoyama, Kazunari K, Hyodo, Ichinosuke, Abei, Masato

“…Advanced liver cancers and biliary cancers represent diseases with dismal prognosis because of frequent local invasion and metastasis. Effective therapeutic…”
Get more information

Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients by CHIBA, Toshiya, TOKUUYE, Koichi, TANAKA, Naomi, AKINE, Yasuyuki, MATSUZAKI, Yasushi, SUGAHARA, Shinji, CHUGANJI, Yoshimichi, KAGEI, Kenji, SHODA, Junichi, HATA, Masaharu, ABEI, Masato, IGAKI, Hiroshi

“…Purpose: We present results of patients with hepatocellular carcinoma (HCC) treated with proton beam therapy. Experimental Design: We reviewed 162 patients…”
Get full text

Clinical Features of Hepatitis E Virus Infection in Ibaraki, Japan: Autochthonous Hepatitis E and Acute-on-Chronic Liver Failure by Inagaki, Yuki, Oshiro, Yukio, Hasegawa, Naoyuki, Fukuda, Kuniaki, Abei, Masato, Nishi, Masaaki, Okamoto, Hiroaki, Ohkohchi, Nobuhiro

“…Hepatitis E caused by hepatitis E virus (HEV) is a serious public health concern in developing countries where HEV is mainly transmitted through contaminated…”
Get full text

Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide by Fukuda, Kuniaki, Mori, Kensaku, Hasegawa, Naoyuki, Nasu, Katsuhiro, Ishige, Kazunori, Okamoto, Yoshikazu, Shiigai, Masanari, Abei, Masato, Minami, Manabu, Hyodo, Ichinosuke

“…Purpose In radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC), it is difficult to assess the ablative margin (AM) precisely by comparing pre- and…”
Get full text

Investigation of the Geometric Accuracy of Proton Beam Irradiation in the Liver by Fukumitsu, Nobuyoshi, M.D, Hashimoto, Takayuki, M.D, Okumura, Toshiyuki, M.D, Mizumoto, Masashi, M.D, Tohno, Eriko, M.D, Fukuda, Kuniaki, M.D, Abei, Masato, M.D, Sakae, Takeji, Ph.D, Sakurai, Hideyuki, M.D

“…Purpose To investigate the geometric accuracy of proton beam irradiation to the liver by measuring the change in Hounsfield units (HUs) after irradiation…”
Get full text

Cyclophosphamide enhances antitumor efficacy of oncolytic adenovirus expressing uracil phosphoribosyltransferase (UPRT) in immunocompetent Syrian hamsters by Hasegawa, Naoyuki, Abei, Masato, Yokoyama, Kazunari K., Fukuda, Kuniaki, Seo, Emiko, Kawashima, Rei, Nakano, Yuri, Yamada, Takeshi, Nakade, Koji, Hamada, Hirofumi, Obata, Yuichi, Hyodo, Ichinosuke

“…Oncolytic viruses (OVs) are novel cancer therapeutics with great promise, but host antiviral immunity represents the hurdle for their efficacy…”
Get full text

Effects of Dipyridamole Coadministration on the Pharmacokinetics of Ribavirin in Healthy Volunteers by Suzuki, Yoshiharu, Homma, Masato, Abei, Masato, Hyodo, Ichinosuke, Kohda, Yukinao

“…Ribavirin (RBV), a guanosine analog for treatment of hepatitis C, is a substrate of a nucleoside transporter, solute carrier family 29 member 1 (SLC29A1). To…”
Get full text

EpCAM‐ and EGFR‐targeted selective gene therapy for biliary cancers using Z33‐fiber‐modified adenovirus by Kawashima, Rei, Abei, Masato, Fukuda, Kuniaki, Nakamura, Kiminori, Murata, Takehide, Wakayama, Mariko, Seo, Emiko, Hasegawa, Naoyuki, Mizuguchi, Hiroyuki, Obata, Yuichi, Hyodo, Ichinosuke, Hamada, Hirofumi, Yokoyama, Kazunari K.

“…A critical issue in adenovirus (Ad)‐based cancer gene therapy is to improve the specificity of gene delivery to cancer cells for better efficacy and safety. We…”
Get full text

Proton Beam Therapy for Aged Patients With Hepatocellular Carcinoma by Hata, Masaharu, M.D, Tokuuye, Koichi, M.D, Sugahara, Shinji, M.D, Tohno, Eriko, M.D, Nakayama, Hidetsugu, M.D, Fukumitsu, Nobuyoshi, M.D, Mizumoto, Masashi, M.D, Abei, Masato, M.D, Shoda, Junichi, M.D, Minami, Manabu, M.D, Akine, Yasuyuki, M.D

“…Purpose To investigate the safety and efficacy of proton beam therapy for aged patients with hepatocellular carcinoma (HCC). Methods and Materials Twenty-one…”
Get full text